www.fiercebiotech.com Open in urlscan Pro
104.18.0.165  Public Scan

Form analysis
0 forms found in the DOM

Text Content

Webinar


FIVE WAYS MEDICAL AFFAIRS CAN IMPACT CLINICAL OUTCOMES

May 17, 2023 2:00pm ET
60 Minutes
Share
share on linkedin
share on twitter
share on facebook
share on email
copy link

Life Sciences organizations want their therapies to be adopted, and guideline
medicine to be used - we have five steps to get there. As the primary interface
between healthcare providers (HCPs) and pharmaceutical companies, medical
affairs teams and medical science liaisons (MSLs) have a unique opportunity to
engage with HCPs in clinical discussions and bridge care gaps by providing
crucial insights into evidence-based medicine. 

 * Identify the HCPs and Orgs that are NOT following guidelines, protocols and
   don’t have the best outcomes (low evidence adherence)
 * Discover the thought leaders who are best qualified and equipped to drive
   adoption and adherence
 * Utilize AI backed technology and insights to help customers map out the best
   strategies to engage high value thought leaders
 * Leverage an omni-channel approach to ensure MSLs and field teams are not
   solely dependent on high-touch outreach tactics
 * Enhance existing measurement and establish a way to validate if strategies
   are driving clinical behavior change, changing sentiment, growing share of
   voice, and improving patient outcomes


SPEAKERS


LORI LEBSON

Head, US Medical Affairs - Neurology & Immunology
EMD Serono

Lori completed her Ph.D. in Neuroimmunology at the University of South Florida.
 After completing her doctorate, she continued her education as a National
Multiple Sclerosis Society Neuroimmunology Postdoctoral Fellow at Johns Hopkins.
Lori has over 10 years of pharmaceutical experience and currently serves as the
head of US Medical Affairs leading the medical director and field MSL team
focused on Neurology and Immunology in market and pipeline portfolio. Prior to
joining EMD Serono Lori worked at Teva Pharmaceuticals within the Neurology
franchise supporting Multiple Sclerosis and Movement Disorders.


STACEY RIVKIN

Group Vice President of Strategic Solutions
H1

Stacey Rivkin is Vice President of Strategic Insights at H1. She leads a team of
subject matter experts that drive and provide strategic insights for clients to
help global pharma and biotech companies optimize strategic engagement for
operational efficiency and commercial growth.

Stacey is considered a strategic partner to H1 clients as she and her team help
organizations build and maintain collaborative, mutually beneficial
relationships with key global external experts and other stakeholders through
optimized identification, profiling, and integrated strategic engagement


REGISTER HERE!

Already registered? Click here to login.
Date/Time:
May 17, 2023 2:00pm ET
Duration:
60 Minutes

 * Connect
   * The Team
   * Advertise
 * Join Us
   * Newsletters
   * Resources
   * RSS Feeds
 * Our Brands
   * Fierce Pharma
   * Fierce Biotech
   * Fierce Healthcare
 * Our Events
   * Life Sciences Events

©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy